Connect with us

Technology

Breast Tissue Expander Market size is set to grow by USD 282.4 million from 2024-2028, Increasing prevalence of breast cancer boost the market, Technavio

Published

on

NEW YORK, July 4, 2024 /PRNewswire/ — The global breast tissue expander market size is estimated to grow by USD 282.4 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  6.78%  during the forecast period. Increasing prevalence of breast cancer is driving market growth, with a trend towards growing awareness programs for breast cancer. However, high costs associated with breast reconstruction surgeries  poses a challenge. Key market players include AbbVie Inc., Establishment Labs Holdings Inc., Global Consolidated Aesthetics Ltd., Groupe SEBBIN SAS, Guangzhou Wanhe Plastic Materials Co. Ltd., Johnson and Johnson Services Inc., PMT Corp., POLYTECH Health and Aesthetics GmbH, Sientra Inc., Silimed Industria de Implantes Ltd., and Specialty Surgical Products Inc..

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

Breast Tissue Expander Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 6.78%

Market growth 2024-2028

USD 282.4 million

Market structure

Concentrated

YoY growth 2022-2023 (%)

6.23

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 36%

Key countries

US, Canada, UK, Germany, and Japan

Key companies profiled

AbbVie Inc., Establishment Labs Holdings Inc., Global Consolidated Aesthetics Ltd., Groupe SEBBIN SAS, Guangzhou Wanhe Plastic Materials Co. Ltd., Johnson and Johnson Services Inc., PMT Corp., POLYTECH Health and Aesthetics GmbH, Sientra Inc., Silimed Industria de Implantes Ltd., and Specialty Surgical Products Inc.

Market Driver

The global breast tissue expander market is witnessing growth due to the rising incidence of breast cancer and associated risk factors. Notable risk factors include genetic mutations, reproductive history, previous radiation therapy, alcohol consumption, and hormone intake. In response, various organizations are promoting education and awareness programs, as well as offering breast screening facilities for early detection. For instance, the Department of Health in Australia operates the BreastScreen Australia program, which invites women aged between 50 and 74 for free mammograms every two years. The government plans to invest USD64.3 million to extend this program to women aged 70-74. Non-government organizations are also launching podcast series to educate the public about breast cancer. These initiatives aim to reduce breast cancer mortality rates and drive market growth throughout the forecast period.

The Breast Tissue Expander market is witnessing significant growth in the Breast Reconstruction market, driven by the rising number of Breast Cancer diagnoses and increasing awareness. Reimbursements for Breast Reconstruction Treatment are also boosting market expansion. Trends include 3D-printed implants using Resomer bioresorbable polymer, silicone implants, and clinical trials for tissue expanders. Mastectomy patients opt for breast prosthetics as alternatives. Product failures and recalls have affected market players like Allergan, impacting the Breast Implants segment. Regulatory challenges and high costs are key concerns. Aging population and demand for cosmetic procedures in Ambulatory Surgical Centers, Hospitals, and Clinics drive market growth. Product shape insights include rectangular, crescent, and round expanders for various reconstructive surgeries and cosmetic procedures. Patient satisfaction, post-surgery complications, scar management, and surgical oncology are critical factors. Other applications include Forehead Skin Reconstruction, Scalp Reconstruction, Face & Neck Reconstruction. Surgical techniques and patient preferences influence market trends. 

Research report provides comprehensive data on impact of trend. For more details- Download a Sample Report

Market Challenges

The global breast tissue expander market growth may be hindered by the high cost of breast reconstruction surgeries. In developing countries like South Africa, the cost of surgery, follow-up fees, diagnostic tests, hospital stays, and breast implants add up to an average cost of USD4,500 for a mastectomy and USD3100USD10,000 for breast reconstruction. These expenses can limit patient access, particularly in countries where medical aid coverage is limited. In the US, while insurance coverage is more extensive, out-of-pocket costs remain significant, with breast reconstruction surgeries costing an average of USD10,000USD30,000 for those uninsured and USD10,000USD12,000 for insured individuals. These high costs may deter patients from seeking necessary treatment, ultimately impacting the demand for breast tissue expanders.The Breast Tissue Expander market is witnessing significant growth due to the increasing demand for reconstructive and cosmetic surgeries. Allergan dominates the Breast Implants segment, but Tissue Expanders are gaining popularity due to their use in various reconstructive procedures. Acellular Dermal Matrix is a key component in tissue expander surgeries, offering advantages in wound closure and tissue regeneration. Challenges in this market include regulatory hurdles, high costs, and patient preferences for ambulatory surgical centers, hospitals, and clinics. Product shape, such as rectangular, crescent, or round, influences surgeon preference and patient satisfaction. Reconstructive surgeries, including Forehead Skin Reconstruction, Scalp Reconstruction, and Face & Neck Reconstruction, also drive demand. Post-surgery complications, scar management, and patient satisfaction are crucial factors. Surgical oncology, Breast Conserving Surgery, and Reconstruction options further expand the market. Quality of life and patient preferences are key drivers, as an aging population seeks various aesthetic procedures.

For more insights on driver and challenges – Request a sample report!

Segment Overview

This breast tissue expander market report extensively covers market segmentation by 

End-user1.1 Hospitals1.2 Cosmetology clinics1.3 Cancer institutesProduct 2.1 Saline-filled breast tissue expanders2.2 Air-filled breast tissue expandersGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Hospitals-  The Breast Tissue Expander market is experiencing significant growth due to increasing breast reconstruction surgeries and the rising preference for aesthetic enhancements. These expanders are used to gradually expand the breast tissue prior to breast implant surgery. Major players in this market include Allergan, Sientra, and Mentor. They invest in research and development to innovate and improve their product offerings. The market is expected to continue expanding due to rising consumer awareness and affordability of these procedures.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report

Research Analysis

The Breast Tissue Expander market is witnessing significant growth due to the increasing awareness and early detection of breast cancer. Reimbursements for breast reconstruction surgeries, including tissue expanders, are driving market expansion. Mastectomy patients often require tissue expanders to prepare the chest wall for breast reconstruction or for those opting for cosmetic procedures. Innovations in medical technology, such as 3D-printed implants and Resomer bioresorbable polymers, are transforming the market. Clinical trials for new tissue expanders and alternatives, like liposuction and acellular dermal matrix, are underway. However, challenges such as capsular contracture, product failures, recalls, and regulatory hurdles pose risks. High costs and the aging population’s increasing demand for aesthetic surgeries are other market drivers. Tissue expanders are also used in reconstructive surgeries for forehead skin reconstruction, scalp reconstruction, face & neck reconstruction, and other applications. Ambulatory Surgical Centers, hospitals, and clinics are key distribution channels.

Market Research Overview

The Breast Tissue Expander market is a subsegment of the larger Breast Reconstruction market, which is driven by the increasing incidence of Breast Cancer and growing awareness about early detection and treatment. Reimbursements for breast reconstruction treatments, including tissue expanders, are a significant factor fueling market growth. Mastectomy and breast prosthetics are common breast reconstruction methods, with tissue expanders used to prepare the breast tissue for implant placement. Innovations in medical technology, such as 3D-printed implants and Resomer bioresorbable polymer, are transforming the market. Clinical trials for new products and surgical techniques are ongoing, with liposuction and capsular contracture being areas of focus. Product failures and recalls have posed challenges to market players, with Allergan’s breast implant scandal being a notable example. The Breast Implants segment, which includes tissue expanders, accounts for a significant share of the market. Reconstructive surgeries and cosmetic procedures are key application areas, with patient preferences and quality of life being crucial factors. Regulatory challenges and high costs are major market restraints, with ambulatory surgical centers, hospitals, and clinics being the primary end-users. Product shape, including rectangular, crescent, and round, is a significant factor influencing patient satisfaction and post-surgery complications. Other applications of tissue expanders include forehead skin reconstruction, scalp reconstruction, face & neck reconstruction, and breast augmentation. Surgical oncology, breast conserving surgery, and reconstruction options are also areas of interest in the market. Patient satisfaction, scar management, and surgical techniques are critical factors influencing market growth. Overall, the Breast Tissue Expander market is expected to grow significantly in the coming years, driven by increasing demand for breast reconstruction treatments, technological innovations, and patient preferences.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

End-userHospitalsCosmetology ClinicsCancer InstitutesProductSaline-filled Breast Tissue ExpandersAir-filled Breast Tissue ExpandersGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/breast-tissue-expander-market-size-is-set-to-grow-by-usd-282-4-million-from-2024-2028–increasing-prevalence-of-breast-cancer-boost-the-market-technavio-302188968.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

THE MINISTRY OF DEFENCE ENHANCES NATIONAL RESILIENCE THROUGH SMART DEFENCE TECHNOLOGY INNOVATION

Published

on

By

KUALA LUMPUR, Malaysia, April 22, 2026 /PRNewswire/ — On April 20, The Prime Minister of Malaysia, YAB Dato’ Seri Anwar bin Ibrahim, officiated the Defence Services Asia (DSA) & National Security (NATSEC) Asia 2026 Opening Ceremony at the Malaysia International Trade and Exhibition Centre (MITEC).

Themed “Enhancing Capabilities and Resilience Through Technology”, the 19th Edition of the DSA 2026 Exhibition will run for four days from 20 to 23 April 2026. This exhibition aims to enhance defence capabilities and drive future technology to ensure national resilience through innovation, international cooperation and the development of the local defence industry ecosystem.

The main focus of this event is on the evolution of defence technology that has shifted from conventional assets to smart systems. Emphasis is placed on mastering technology that is capable of facing the security threats of the new millennium which are asymmetric and hybrid in nature.

Among the core advanced technologies featured :

a) Autonomous & Robotic Systems: Exhibition of various variations of unmanned systems (UAV, UGV, and UUV) equipped with Artificial Intelligence (AI) for long-distance monitoring and detection operations.

b) Digital & Cyber Defence: Application of new generation encryption technology and cybersecurity platforms to protect the country’s data sovereignty and critical infrastructure.

c) Sensor & Electronic Technology: High-precision radar and sensor systems that enable ATM readiness to be at an optimal level in monitoring space, maritime, and land in real-time.

In line with this global technology exposure, the government continues to strengthen the Industrial Collaboration Programme (ICP) as the main mechanism for technology transfer. Through the ICP, the involvement of international industry players is required to contribute to the development of local talent and research and development (R&D) in the high-tech sector.

Among the key segments highlighted are the CBRNe Arena, focusing on technologies related to chemical, biological, radiological, nuclear and explosive threats; the Firearms and Tactical Equipment Segment, showcasing the latest operational capabilities and equipment; and the Coalition of Defence Industry Malaysia (CDIM) Pavilion, which highlights the capabilities of the country’s defence industry. The DSA & NATSEC Asia Lab also showcases innovation initiatives by providing a platform for small and medium-sized enterprises (SMEs) and start-ups to introduce their innovations on the international stage.

This edition recorded the participation of 1,456 companies from 63 countries, including 37 international pavilions, as well as approximately 600 official delegations and 50,000 trade visitors from more than 114 countries within the 48,000-square-metre exhibition space. This scale of participation reflects the strategic importance of the exhibition at the global level and further demonstrates Malaysia’s position as a strategic meeting point for defence and security cooperation.

Also present were the Minister of Defence, YB Dato’ Seri Mohamed Khaled Nordin; Chief Secretary to the Government, Tan Sri Shamsul Azri Abu Bakar; Speaker of the Dewan Rakyat, Tan Sri Dato’ Dr. Johari bin Abdul; Chairman of DSA Exhibition and Conference Sdn Bhd, Tan Sri Asmat Kamaludin; Chief of Defence Force, General Datuk Haji Malek Razak bin Sulaiman; Secretary-General of the Ministry of Defence, Datuk Lokman Hakim bin Ali; Deputy Minister of Defence, YB Adly Zahari; as well as top management and senior officers of the Ministry and the Malaysian Armed Forces.

– END –

“‘MALAYSIA MADANI” “BERKHIDMAT UNTUK NEGARA”
”PERTAHANAN NEGARA, TANGGUNGJAWAB BERSAMA”

Ministry of Defence Malaysia
20 April 2026

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/the-ministry-of-defence-enhances-national-resilience-through-smart-defence-technology-innovation-302749464.html

SOURCE DSA & NATSEC ASIA

Continue Reading

Technology

Grantd Launches Platform to Help Employees Understand Their Equity, Build Confidence in Their Financial Plan, and Connect to Advice When They Need It

Published

on

By

New Platform Gives Every Equity Recipient a Personalized View of Their Awards — and a Clear Path to Understand, Act, and Get Advice on Them

DENVER, April 21, 2026 /PRNewswire-PRWeb/ — Grantd, an AI-powered equity compensation platform whose advisor platform helps advisors manage over $14 billion in assets under administration for more than 400 registered investment advisory firms and 14,000 clients, today announced the launch of its issuer platform, Grantd for Work. The platform is built to give employees a clear, personalized understanding of their equity compensation — what they have, what it’s worth, how it fits into their broader financial picture, and what they should consider doing about it. Equity compensation is complex, and for most employees, it has been difficult to navigate without dedicated resources and support. Grantd for Work changes that — providing the tools, education, and guidance employees need to understand their awards with confidence, and connecting them to a financial advisor when they’re ready to take the next step.

“It gives every employee a real, personalized view of their equity — what it means for their financial goals, what actions they should consider, and a direct line to advice when they need it.”

The launch marks a significant expansion of Grantd’s reach — from individual equity recipients and their financial advisors to the employers and employees inside the companies that grant those awards. It also helps HR and compensation administrators gain better visibility into their programs, reduce the volume of manual employee questions, and identify where engagement and retention may be at risk.

“Equity is one of the most powerful forms of compensation companies offer — but for most employees, it’s also one of the least understood,” said Brian McDonald, Founder & CEO of Grantd. “An employee might receive an RSU grant, watch it vest, and still have no idea what the tax implications are, whether they should sell or hold, or how it changes their financial picture. Grantd for Work changes that. It gives every employee a real, personalized view of their equity — what it means for their financial goals, what actions they should consider, and a direct line to advice when they need it.”

Grantd for Work is built around the employee experience. Key capabilities include:

A personalized equity dashboard showing each employee’s total portfolio value, vested and unvested equity broken down by grant, external holdings, and concentration risk — giving them a complete, real-time picture of what they own, what it’s worth, and how it fits into their overall financial picture.AI-powered document reading that automatically extracts holdings from any brokerage statement or equity award summary — from any provider — so the platform is accurate and fully populated from day one, with no manual entry required.Financial goal tracking that maps each employee’s equity directly to their personal financial goals — financial independence, early retirement, a home purchase — showing whether they’re on track, what’s at risk, and how upcoming vests and exercises could change the outcome.A full equity planning toolkit, including concentration analysis, price target modeling, growth scenario projections, exercise planning, withholding analysis, and trading window tracking — alongside pre-built strategy templates like sell-to-cover, diversification sell-down, and automated trading plans.Ask Grant, an AI equity guide built directly into the platform that answers employees’ most pressing questions — from how RSU income is taxed at vest to what the ESPP 15% discount means for their tax situation — in plain language, on demand.AI agents that work for every employee — Grantd’s AI agents don’t wait to be asked. They continuously analyze each employee’s equity portfolio and surface timely, personalized insights. Every insight is specific to that employee — not generic equity education, but guidance grounded in what they actually hold.A learning center with articles and guides covering equity basics, tax and finance, investing strategy, and company-specific plan guides — so employees can build real confidence in their equity, not just access to it.A direct connection to financial advice when employees are ready to go beyond self-service — with their complete equity profile already structured and ready to share with an advisor.

For HR and compensation administrators, the platform also provides visibility into how equity programs are performing across the organization — including a live dashboard of total equity wealth created by employee, department, and level; proactive retention signals for employees with expiring grants or low engagement; and competitive equity modeling tools to help design compelling offers for prospective hires.

The new platform arrives at a time when industry leaders are rethinking equity program design and employee share plan strategy. Grantd will further that conversation at the Global Equity Organization’s (GEO) 27th Annual Conference in Austin, taking place April 21–23, 2026. On Wednesday, April 22, Brian McDonald will join the expert panel, “Strategic Shifts in Employee Share Plans: How Companies Are Redesigning Equity for 2026 and Beyond,” alongside fellow Grantd Advisory Board members Billy Vitense of Starbucks, Christine Zwerling of Asana, and Melissa Howell of Nike.

To learn more about Grantd for Work or schedule a demonstration, visit Grantd online at https://www.grantdequity.com/.

About Grantd:

Founded by Brian McDonald, Grantd is an AI-powered equity compensation platform built to simplify how equity is understood, managed, and acted on. Its advisor platform manages over $14 billion in assets under administration for more than 400 registered investment advisory firms, 2,600 advisors, and 14,000 clients. With the launch of Grantd for Work, the company now serves the full equity ecosystem — from individual equity recipients and their advisors to the employees who hold those awards and the HR and compensation teams who design and run the programs. Grantd is headquartered in Denver, Colorado.

Media Contact

Jane Kim, Grantd Equity, 1 (303) 515-3158, jane.kim@grantdequity.com, grantdequity.com

View original content:https://www.prweb.com/releases/grantd-launches-platform-to-help-employees-understand-their-equity-build-confidence-in-their-financial-plan-and-connect-to-advice-when-they-need-it-302745530.html

SOURCE Grantd Equity

Continue Reading

Technology

FERMI PROVIDES BUSINESS UPDATE

Published

on

By

DALLAS, April 21, 2026 /PRNewswire/ — Fermi Inc. (d/b/a Fermi America) (NASDAQ: FRMI) (LSE: FRMI), operating as Fermi America™ (“Fermi” or the “Company”), subsequent to the Company’s announcement of Fermi 2.0 on April 20, 2026, has received significant and positive feedback from multiple potential tenants, the Company’s landlord, the Texas Tech University System, as well as suppliers, vendors, contractors, financing sources, and other partners. The Company is gratified by that feedback and is pursuing Fermi 2.0’s business and leadership objectives with all deliberate speed.

The Company also acknowledges receipt of a letter from Mr. Toby Neugebauer, and has reviewed a press release issued by him, calling for the initiation of a process for the immediate sale of the Company. As Mr. Neugebauer indicated in his press release, he was removed from his position on April, 17, 2026,  after careful consideration by the Company’s Board of Directors in accordance with its fiduciary duties. Given recent changes in leadership, which position the Company for its next chapter of growth and evolution from a startup to a scaled enterprise, the Company firmly believes a sale is not in the best interest of its continued momentum on Project Matador, ability to serve potential tenants and long-term value creation for shareholders. The Board, consistent with its fiduciary duties, will carefully review all avenues to maximize shareholder value, which include continued execution of its business plan, strategic investments from third parties, joint ventures or other transactions.

About Fermi America™

Fermi America™ (NASDAQ & LSE: FRMI) (fermiamerica.com) is pioneering the development of next-generation private electric grids that deliver highly redundant power at gigawatt scale, required to create next-generation artificial intelligence. Co-founded by former U.S. Energy Secretary Rick Perry and Co-Founder and former Co-Managing Partner of Quantum Energy Toby Neugebauer, Fermi America™ combines cutting-edge technology with a deep bench of proven world-class multi-disciplinary leaders to create the world’s largest, 17 GW next-generation private HyperGrid campus. Project Matador is expected to integrate the nation’s biggest combined-cycle natural gas project, one of the largest clean, new nuclear power complexes in America, utility grid power, solar power, and battery energy storage, to deliver hyperscaler artificial intelligence.

Additional Information and Where to Find It

If the Company determines to hold a special meeting of shareholders, the Company will file a proxy statement on Schedule 14A, an accompanying white proxy card and other relevant documents with the Securities and Exchange Commission (the “SEC”) in connection with the solicitation of proxies from the Company’s shareholders for such meeting. SHAREHOLDERS OF THE COMPANY ARE STRONGLY ENCOURAGED TO READ THE COMPANY’S DEFINITIVE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO), IF ANY, AND ALL OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY, IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and shareholders may obtain a copy of any definitive proxy statement of the Company, an accompanying white proxy card, any amendments or supplements thereto and other documents filed by the Company with the SEC if and when they become available at no charge at the SEC’s website at www.sec.gov. Copies will also be available at no charge in the “SEC Filings” subsection of the Company’s Investor Relations website at https://fermiamerica.com/ or by contacting the Company’s Investor Relations Department at IR@fermiamerica.com, as soon as reasonably practicable after such materials are electronically filed with, or furnished to, the SEC.

Participants in the Solicitation

If the Company determines to hold a special meeting of shareholders, the Company, its directors and certain of its executive officers may be deemed participants in the solicitation of proxies from the Company’s shareholders in connection with matters to be considered at such special meeting of shareholders. Information regarding the direct and indirect interests, by security holdings or otherwise, of the Company’s directors and executive officers is included in the Company’s final prospectus, filed with the SEC on October 1, 2025, the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 30, 2026, and in the Company’s Current Reports on Form 8-K filed with the SEC from time to time. Changes to the direct or indirect interests of the Company’s directors and executive officers are set forth in SEC filings on Initial Statements of Beneficial Ownership on Form 3 or Statements of Change in Ownership on Form 4. These documents are available free of charge as described above. Updated information regarding the identities of potential participants and their direct or indirect interests, by security holdings or otherwise, in the Company will be set forth in the definitive proxy statement for the Company’s special meeting of shareholders and other relevant documents to be filed with the SEC, if and when they become available.

Forward-Looking Statements

Statements contained in this press release which are not historical facts, such as those relating to future events, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Fermi undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Investors should consult further disclosures and risk factors included in our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, the Registration Statement on Form S-8 and other documents filed from time to time with the SEC by Fermi.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/fermi-provides-business-update-302749474.html

SOURCE Fermi Inc.

Continue Reading

Trending